Jazz Pharmaceuticals plc
US ˙ NasdaqGS ˙ IE00B4Q5ZN47

SecurityJAZZ / Jazz Pharmaceuticals plc
InstitutionSignaturefd, Llc
Latest Disclosed Ownership71 shares
Latest Disclosed Value $ 13,423
Signaturefd, Llc ownership in JAZZ / Jazz Pharmaceuticals plc

On April 7, 2026 - Signaturefd, Llc filed a 13F-HR form disclosing ownership of 71 shares of Jazz Pharmaceuticals plc (US:JAZZ) valued at $13,423 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 71 shares of Jazz Pharmaceuticals plc. This represents a change in shares of 0.00% during the quarter. The current value of the position is $16,938 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 71 0 0.00 13 8.33 0.0002
2026-01-20 2025-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 71 0 0.00 12 33.33 0.0002
2025-10-21 2025-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 71 -79 -52.67 9 -40.00 0.0001
2025-07-16 2025-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 150 -1,388 -90.25 16 -92.11 0.0003
2025-05-02 2025-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 1,538 52 3.50 191 3.83 0.0036
2025-02-10 2024-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 1,486 -30 -1.98 183 8.93 0.0035
2024-10-21 2024-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 1,516 1,110 273.40 169 290.70 0.0032
2024-07-29 2024-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 406 -15 -3.56 43 -14.00 0.0009
2024-05-03 2024-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 421 -112 -21.01 51 -23.08 0.0011
2024-02-01 2023-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 533 -13 -2.38 66 -7.14 0.0015
2023-11-03 2023-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 546 252 85.71 71 94.44 0.0018
2023-08-01 2023-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 294 -77 -20.75 36 -33.33 0.0009
2023-04-28 2023-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 371 41 12.42 54 3.85 0.0015
2023-01-30 2022-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 330 -31 -8.59 53 8.33 0.0015
2022-11-08 2022-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 361 -25 -6.48 48 -20.00 0.0016
2022-08-10 2022-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 386 22 6.04 60 5.26 0.0020
2022-05-02 2022-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 364 19 5.51 57 29.55 0.0017
2022-01-25 2021-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 345 -70 -16.87 44 -18.52 0.0014
2021-10-28 2021-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 415 -41 -8.99 54 -33.33 0.0019
2021-07-26 2021-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 456 46 11.22 81 20.90 0.0032
2021-04-30 2021-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 410 4 0.99 67 0.00 0.0030
2021-02-11 2020-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 406 32 8.56 67 26.42 0.0032
2020-11-03 2020-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 374 34 10.00 53 39.47 0.0028
2020-07-30 2020-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 340 80 30.77 38 46.15 0.0023
2020-04-23 2020-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 260 134 106.35 26 36.84 0.0022
2020-02-05 2019-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 126 -40 -24.10 19 -9.52 0.0014
2019-10-16 2019-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 166 -34 -17.00 21 -27.59 0.0017
2019-07-31 2019-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 200 72 56.25 29 61.11 0.0025
2019-05-09 2019-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 128 38 42.22 18 63.64 0.0015
2019-02-13 2018-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 90 -160 -64.00 11 -73.81 0.0010
2018-11-14 2018-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 250 -12 -4.58 42 -6.67 0.0043
2018-08-14 2018-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 262 72 37.89 45 55.17 0.0050
2018-05-08 2018-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 190 190 29 0.0034
2017-02-14 2016-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 0 -52 -100.00 0 -100.00
2016-11-14 2016-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 52 0 0.00 6 -14.29 0.0009
2016-07-29 2016-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 52 13 33.33 7 40.00 0.0010
2016-05-12 2016-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 39 4 11.43 5 0.00 0.0009
2016-01-22 2015-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 35 35 5 0.0010
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.